KRAS and neoplasm: This analysis confirmed the successful establishment of the murine model and accurate recapitulation of the parental tumor's mutational background identifying a missense mutation in the Kras gene (G12V), a deletion in Trp53 (Δ2-10), and an exon 3 deletion in Ctnnb1, all of which were retained in the organoids.